CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 211 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,000 | +28.6% | 676 | +6.6% | 0.00% | – |
| Q2 2023 | $14,000 | +7.7% | 634 | +8.0% | 0.00% | – |
| Q1 2023 | $13,000 | +30.0% | 587 | +20.0% | 0.00% | – |
| Q4 2022 | $10,000 | -68.8% | 489 | -60.5% | 0.00% | – |
| Q3 2022 | $32,000 | +52.4% | 1,238 | +38.5% | 0.00% | – |
| Q2 2022 | $21,000 | +110.0% | 894 | +104.1% | 0.00% | – |
| Q1 2022 | $10,000 | -98.8% | 438 | -99.2% | 0.00% | -100.0% |
| Q3 2019 | $825,000 | +65.3% | 58,368 | +30.5% | 0.00% | +33.3% |
| Q2 2019 | $499,000 | +113.2% | 44,710 | +124.2% | 0.00% | +200.0% |
| Q1 2019 | $234,000 | -32.4% | 19,938 | -19.1% | 0.00% | -50.0% |
| Q3 2018 | $346,000 | – | 24,644 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
| INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
| GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
| Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
| Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
| FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
| MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
| Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |